Apex Healthcare Berhad operates as an investment holding entity primarily engaged in the pharmaceutical and healthcare industry. Its comprehensive operations span the development, production, promotion, distribution, and wholesale of a wide array of health-related goods. The company segments its activities into Manufacturing, Distribution, and Corporate functions. Its extensive pharmaceutical range addresses various health needs, offering solutions for coughs and allergies, anti-infectives, anti-diabetics, anti-hypertensives, neuromuscular agents, pain relievers, dermatological applications, and ophthalmological preparations. These come in diverse formats such as tablets, capsules, oral liquids and suspensions, creams, and sterile eye drops, often marketed under its flagship Xepa brand. Beyond its pharmaceutical offerings, Apex Healthcare also specializes in contract manufacturing of orthopedic devices, components, and surgical tools. This includes creating specialized orthopedic parts vital for surgical interventions treating musculoskeletal disorders caused by trauma, illnesses, injuries, or congenital conditions. Further diversifying its business, the company also engages in pharmaceutical retail, manages and leases properties, oversees brand development, and provides accounting and management consultancy services. Its broad portfolio of brands includes XEPA, AVO, AGNESIA, AEVA, HENNSON, REMECO, KAPS, AVEX, and AVO DIAGNOSTICS. Consumers can access these products through both traditional retail stores and digital e-commerce channels. Founded in 1962 and headquartered in Melaka, Malaysia, Apex Healthcare maintains a significant operational footprint across Malaysia, Singapore, and other international territories.